Pattern of dopaminergic loss in the striatum of humans with parkinsonism induced by MPTP.
Sawle
G V
GV
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000009:adverse effects*; D016923:Cell Death / Q000502:physiology*; D003342:Corpus Striatum / Q000473:pathology* / Q000503:physiopathology; D004298:Dopamine / Q000502:physiology*; D006801:Humans; D009474:Neurons / Q000473:pathology* / Q000502:physiology; D010302:Parkinson Disease, Secondary / Q000209:etiology / Q000473:pathology* / Q000503:physiopathology
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D004298:Dopamine